News | Stroke | June 02, 2023

Study Finds Distinct Patterns of Pre-existing Brain Health Characteristics in Stroke Patients

University of Cincinnati stroke researchers present at international conference 

University of Cincinnati stroke researchers present at international conference

Achala Vagal, MD. Photo/Ravenna Rutledge/UC Marketing + Brand.


June 2, 2023 — University of Cincinnatiresearchers presented abstracts at the European Stroke Organization Conference(ESOC) 2023, May 24-26 in Munich, Germany, including the results of the first large-scale assessment of radiological brain health in stroke patients in a population.  

Extensive research has helped pinpoint risk factors for initial stroke, but there is limited understanding about what the brains of stroke patients look like on a population level, according to UC’s Achala Vagal, MD, professor of neuroradiology.  

“Imaging can be an objective manifestation of the presence and severity of clinical factors such as diabetes, hypertension, high cholesterol and kidney failure,” she said. “However, the majority of the large epidemiological studies of brain health have been performed in stroke-free subjects.”  

Vagal was a co-principal investigator on the Assessing Population-based Radiological brain health in Stroke Epidemiology(APRISE) study that gained new information from neuroimaging results of stroke patients. 

The research team analyzed all available clinical imaging data from nearly 3,500 patients who had a stroke in the Greater Cincinnati/Northern Kentucky region in 2015, assessing the imaging for signs of small vessel disease in the brain in the form of previous injury, microbleeds, white matter disease (wearing away of tissue) or brain atrophy, among other observations.   

Vagal said the team identified three distinct clusters of observable imaging characteristics that were each associated with a specific set of clinical variables.   

“This can help us understand the biology of preexisting brain health in stroke patients and help guide future interventions,” she said. “We expected all the imaging parameters of brain health due to small vessel disease to be closely clustered, but we found a lack of clustering of microbleeds with white matter disease.”  

With the knowledge gained from the study, Vagal said the team is now using the brain health imaging data to build a prediction model of recurrent stroke.  

“Such large-scale characterization of preexisting brain health is helpful to identify novel observable characteristics which can guide further studies,” she said.  

Vagal presented the oral abstract “Radiological Phenotypes of Brain Health in a Stroke Population: Primary Results of the Assessing Population-Based Radiological Brain Health in Stroke Epidemiology (APRISE) Study'' during the Imaging scientific communication session Thursday, May 25.   

Other abstract co-authors include UC’s Heidi Sucharew, Vivek Khandwala, Lily Wang, Rebecca Cornelius, Mary Gaskill-Shipley, Thomas Tomsick, Shantala Gangatirkar, Brady Williamson, Thomas Maloney, Mary Haverbusch, Janice Carrozzella, Kathy Alwell, David Robinson, Robert Stanton and co-principal investigators Pooja Khatri, MD, and Brett Kissela, MD; Paul Horn of Cincinnati Children’s Hospital Medical Center; David Wang of the I-MED Radiology Network in Melbourne, Australia; and Dawn O. Kleindorfer of the University of Michigan.  

Other presentations from UC researchers include: 

For more information: https://www.uc.edu


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now